foxo4-dri senolytic 2024 animal model

foxo4-dri senolytic 2024 animal model induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation Heterogeneity of Cellular Senescence, Senotyping,

Name: foxo4-dri senolytic 2024 animal model induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation Heterogeneity of Cellular Senescence, Senotyping,
Brand: crisbcreativa.com
SKU: 36638541902
Price: 27.13 USD
Availability: InStock
Rating: 4.720000000000001 (23 reviews)

Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases[v1] The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI 10mg vial Description RCpeptides

SKU: 36638541902 · From crisbcreativa.com

4.7

USD27.13 USD76.13

Pay in 4 interest-free payments of $6.78 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

72 GengJ.LiuW.GaoJ.JiangC.FanT.SunY.et al (2019)

Previous studies revealed that the electrospun solution condition (including viscosity, charge density and shear stress) and solvent vapor pressure can simultaneously affect the fiber diameter distribution [52]